Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

Hypertension associated with greater risk of dying from COVID-19—but RAAS inhibitors can help

Hypertension is associated with a much greater risk of dying from COVID-19, according to new research published in European Heart Journal. The study’s authors noted that outcomes improved if patients took antihypertensive medications as recommended.

Thumbnail

Hospital allegedly lied about COVID-19 patient’s death

The hospital is accused of listing an acute myocardial infarction as the cause of the patient’s death and not mentioning COVID-19 at all.

Thumbnail

American College of Cardiology launches new series of COVID-19-related virtual meetings

No registration is required for this series of free virtual meetings.

Thumbnail

How one specialty hospital has kept COVID-19 at bay

The Montreal Heart Institute has been able to operate at a normal pace and keep COVID-19 at bay—and its specialists think other hospitals could learn a thing or two from their experience.

Abiomed gains FDA approval to launch first-in-human trial for ‘world’s smallest heart pump’

The device will be tested in high-risk percutaneous coronary intervention (PCI) patients.

Thumbnail

Indoor air filters associated with a significant decrease in systolic blood pressure

Ambient air pollution directly leads to poorer health outcomes, and even short-term exposure to fine particulate matter can increase a person’s risk of adverse cardiovascular events.

Thumbnail

HHS increases reporting requirements for COVID-19 testing

HHS has announced new laboratory data reporting guidance for COVID-19 testing, expanding requirements for laboratories to report demographic details that can help improve the public response.

Welldoc receives additional FDA approval for digital diabetes solution

Welldoc, a Columbia, Maryland-based digital health company, has gained an additional FDA approval for its BlueStar diabetes management solution.